Advancing novel therapies for neurodegeneration through an innovative model for industry–academia collaborations: A decade of the Eisai

登录注册会员服务联系我们

Advancing novel therapies for neurodegeneration through an innovative model for industry–academia collaborations: A decade of the Eisai–UCL experience

Published:2023-10 Issue:10 Volume:28 Page:103732
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Atkinson Peter J.,Swami Meera,Ridgway Nicola,Roberts Malcolm,Kinghorn Jane,Warner Thomas T.,Staddon James M.,Takle Andrew K.

Funder

Eisai Canada

Eisai

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference29 articles.

1. Models for open innovation in the pharmaceutical industry;Schuhmacher;Drug Discov Today,2013

2. Racing to define pharmaceutical R&D external innovation models;Wang;Drug Discov Today,2015

3. Open innovation in early drug discovery: roadmaps and roadblocks;Reichman;Drug Discov Today,2016

4. Applying open innovation strategies in the context of a regional innovation ecosystem: the case of Janssen Pharmaceuticals;Robaczewska;Glob Transit,2019

5. Alzheimer's disease drug-development pipeline: few candidates, frequent failures;Cummings;Alzheimers Res Ther,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Introduction to Neurodegenerative Diseases;Advances in Medical Diagnosis, Treatment, and Care;2024-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP